Beyond the Box: Pharma’s Untapped Sustainability Goldmine

While primary packaging often dominates sustainability conversations, this session explores the untapped potential of secondary packaging as a strategic lever for pharmaceutical companies navigating the EU's evolving regulatory landscape. With the sustainable pharmaceutical packaging market projected to reach $220 billion by 2030 (CAGR 14.2%), and the PPWR setting mandatory recyclability targets for 2030, secondary packaging presents an immediate opportunity to accelerate compliance and environmental performance.

This session examines how optimised material selection, enhanced recyclability, and improved transport efficiency in secondary packaging can simultaneously reduce environmental impact and strengthen supply chain resilience. Drawing on real-world collaborations with leading EU pharma companies, attendees will gain practical frameworks to position secondary packaging not as a logistical afterthought, but as a vital contributor to competitive, circular, lower-impact pharmaceutical supply chains.